Celestica, Inc. $CLS Shares Sold by Atria Investments Inc

Atria Investments Inc reduced its position in shares of Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS) by 11.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,035 shares of the technology company’s stock after selling 395 shares during the period. Atria Investments Inc’s holdings in Celestica were worth $474,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLS. Bank of New York Mellon Corp boosted its position in shares of Celestica by 22.3% during the 1st quarter. Bank of New York Mellon Corp now owns 121,467 shares of the technology company’s stock valued at $9,573,000 after purchasing an additional 22,120 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Celestica by 9.3% during the first quarter. Envestnet Asset Management Inc. now owns 144,083 shares of the technology company’s stock valued at $11,359,000 after purchasing an additional 12,279 shares during the last quarter. Cerity Partners LLC boosted its holdings in Celestica by 12.3% during the first quarter. Cerity Partners LLC now owns 11,328 shares of the technology company’s stock worth $893,000 after buying an additional 1,245 shares in the last quarter. CWM LLC grew its position in Celestica by 603.7% in the first quarter. CWM LLC now owns 1,921 shares of the technology company’s stock worth $151,000 after buying an additional 1,648 shares during the last quarter. Finally, Signaturefd LLC grew its position in Celestica by 11.1% in the first quarter. Signaturefd LLC now owns 3,829 shares of the technology company’s stock worth $302,000 after buying an additional 383 shares during the last quarter. 67.38% of the stock is currently owned by institutional investors.

Celestica Stock Up 7.0%

NYSE:CLS opened at $344.57 on Tuesday. The business’s fifty day moving average price is $269.81 and its 200 day moving average price is $191.26. The firm has a market capitalization of $39.63 billion, a price-to-earnings ratio of 55.94 and a beta of 1.85. The company has a current ratio of 1.47, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37. Celestica, Inc. has a 1-year low of $58.05 and a 1-year high of $363.40.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last announced its quarterly earnings data on Monday, October 27th. The technology company reported $1.58 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.13. The firm had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.01 billion. Celestica had a return on equity of 30.53% and a net margin of 6.35%.The business’s quarterly revenue was up 27.8% compared to the same quarter last year. During the same period last year, the company posted $1.04 EPS. On average, sell-side analysts forecast that Celestica, Inc. will post 4.35 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Laurette T. Koellner acquired 6,000 shares of the company’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average price of $341.67 per share, for a total transaction of $2,050,020.00. Following the purchase, the director owned 6,000 shares in the company, valued at $2,050,020. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.52% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on CLS shares. BNP Paribas reiterated an “outperform” rating and set a $300.00 price objective on shares of Celestica in a research report on Thursday, September 25th. Stifel Nicolaus reaffirmed a “buy” rating and set a $385.00 target price (up from $230.00) on shares of Celestica in a research report on Wednesday, October 29th. BMO Capital Markets set a $370.00 price target on Celestica and gave the company an “outperform” rating in a research report on Wednesday, October 29th. JPMorgan Chase & Co. lifted their price target on Celestica from $295.00 to $360.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Finally, CIBC boosted their price objective on Celestica from $315.00 to $400.00 and gave the stock an “outperform” rating in a report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Celestica has a consensus rating of “Moderate Buy” and an average target price of $336.00.

Get Our Latest Analysis on Celestica

Celestica Profile

(Free Report)

Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.

See Also

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.